APSR2026-1066

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-024
P101
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245560-46904-APSR26 Med LAD in ILD.pptx_433634.pdf
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Rasheeka VP * Apollo Speciality Hospital, Jayanagar Pulmonology Bengaluru India
Ravindra Mehta - Apollo Speciality Hospital, Jayanagar Pulmonology Bengaluru India
Hariprasad Kalpakam - Apollo Speciality Hospital, Jayanagar Pulmonology Bengaluru India
Sameer Bansal - Apollo Speciality Hospital, Jayanagar Pulmonology Bengaluru India
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Rasheeka
VP
rashika2695@gmail.com
+918861693140
Under 30
India
Original Research
Decoding Mediastinal Lymphadenopathy in ILD Using Combined EBUS-TBNA and TBLC
Maximum 25 words
Abstract Content
Beyond imaging, mediastinal lymphadenopathy in interstitial lung disease (ILD) has uncertain clinical relevance. We aimed to define its etiology and determine its added value to multidisciplinary discussion (MDD) using combined Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transbronchial lung cryobiopsy (TBLC).
We retrospectively reviewed patients with suspected ILD and mediastinal lymphadenopathy(>10 mm on CT) who underwent combined bronchoalveolar lavage, EBUS-TBNA, and TBLC between November 2015 and June 2026 at a tertiary pulmonology centre. Cytopathological, histopathological, microbiological, and clinical data were analysed. Diagnostic yield of EBUS-TBNA, final ILD diagnoses on MDD, and procedural safety were assessed.
Seventy-six patients (median age 59 years; 59% female) underwent the procedure. EBUS-TBNA provided diagnostic yield in 12/76 patients (15.8%), identifying granulomatous lymphadenitis in 10.5%, malignancy in 2.6%, and lymphoproliferative disorder in 1.3%. Most (84.2%) demonstrated reactive lymphadenitis. Notably, granulomatous lymphadenitis was observed in non-sarcoidosis ILDs, including hypersensitivity pneumonitis (15%) and non-specific interstitial pneumonitis (NSIP). No mycobacterial infection was detected. Procedure-related complications matched expected TBLC risk: pneumothorax in 15.8% (11.8% requiring drainage), bleeding in 5.3%, and zero mortality.
Combined EBUS-TBNA with TBLC is a safe, complementary approach providing enhanced pathological insight into mediastinal lymphadenopathy in ILD. While most cases are reactive, a notable subset demonstrates granulomatous pathology in non-sarcoid ILDs, suggesting phenotypic heterogeneity. Routine nodal sampling during TBLC may enhance diagnostic accuracy and should be considered in selected ILD patients. The absence of mycobacterial signals in a tuberculosis-endemic region supports a non-infectious etiology. Furthermore, EBUS-TBNA can be performed safely without increasing procedural risk
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Mediastinal lymphadenopathy, Interstitial lung disease
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no potential conflicts of interest relative to this abstract
257